Brian Van Ness
Impact in
- Hematology top 0.1%
- Multiple Myeloma Research and Treatments
- Oncology top 1%
- Peptidase Inhibition and Analysis
Papers in
- Hematology 65
- Multiple Myeloma Research and Treatments 62
- Oncology 31
- Peptidase Inhibition and Analysis 10
- Co-authors
- Martin M. Oken (19 shared papers)Daniel D. Billadeau (13 shared papers)Robert A. Kyle (16 shared papers)RAFAEL RICARDO AURELIANO DA FONSECA (8 shared papers)Philip R. Greipp (12 shared papers)Patricia Theresa Greipp (8 shared papers)Neil E. Kay (15 shared papers)Kimberly J. Henderson (6 shared papers)
- Journals
- Blood (26 papers)Leukemia (14 papers)Nucleic Acids Research (5 papers)The Journal of Law Medicine & Ethics (4 papers)British Journal of Haematology (3 papers)
- Partner nations
- United StatesFrancePoland
In The Last Decade
Brian Van Ness
102 papers receiving 6.2k citations
Brian Van Ness's Hit Papers
Peers
Comparison fields: 5 of 109
- Hematology 4.5k
- Oncology 2.1k
- Genetics 815
- Molecular Biology 3.6k
- Immunology 642
Countries citing papers authored by Brian Van Ness
This map shows the geographic impact of Brian Van Ness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Van Ness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Van Ness more than expected).
Fields of papers citing papers by Brian Van Ness
This network shows the impact of papers produced by Brian Van Ness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Van Ness. The network helps show where Brian Van Ness may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Van Ness, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | International Myeloma Working Group molecular classification of multiple myeloma: spotlight review Hit paper breakdown → | 2009 | 720 |
| 2 | Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study Hit paper breakdown → | 2011 | 652 |
| 3 | 2003 | 555 | |
| 4 | 2003 | 329 | |
| 5 | 2002 | 278 | |
| 6 | 1993 | 210 | |
| 7 | 1996 | 192 | |
| 8 | 1998 | 161 | |
| 9 | Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study. | 2002 | 161 |
| 10 | 1992 | 158 | |
| 11 | 2008 | 145 | |
| 12 | 2005 | 135 | |
| 13 | 2007 | 125 | |
| 14 | 1991 | 120 | |
| 15 | 2001 | 118 | |
| 16 | 1996 | 99 | |
| 17 | 1996 | 98 | |
| 18 | 2011 | 93 | |
| 19 | 2011 | 90 | |
| 20 | Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6. | 1995 | 89 |
About Brian Van Ness
Brian Van Ness is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Immunology, having authored 103 papers that have together received 6.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (62 papers), Protein Degradation and Inhibitors (21 papers), T-cell and B-cell Immunology (15 papers), Monoclonal and Polyclonal Antibodies Research (14 papers), Chronic Lymphocytic Leukemia Research (12 papers), Glycosylation and Glycoproteins Research (11 papers), Peptidase Inhibition and Analysis (10 papers) and Ethics in Clinical Research (8 papers). The work is most often cited by research in Hematology (4.5k citations), Oncology (2.1k citations), Genetics (815 citations), Molecular Biology (3.6k citations) and Immunology (642 citations). Brian Van Ness has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Martin M. Oken, Daniel D. Billadeau, Robert A. Kyle, RAFAEL RICARDO AURELIANO DA FONSECA, Philip R. Greipp, Patricia Theresa Greipp, Neil E. Kay, Kimberly J. Henderson, Emily Blood and David T. Harrington. Their work appears in journals such as Blood, Leukemia, Nucleic Acids Research, The Journal of Law Medicine & Ethics and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.